Pisciotto PTTransfusion reactions. In Pisciotto PT, ed. Blood Transfusion Therapy. A Physician's Handbook , 3rd ed. Arlington, Va.: American Association of Blood Banks, 1989, pp 77-85.
2.
Goodnough LT , Shuck JMRisks, options and informed consent for blood transfusion in elective surgery. Am J Surg159:602-607, 1990.
3.
Aubuchon JP, Busch M., Epstein JS, et al. Increasing the Safety of Blood Transfusions. Washington, D.C.: American Red Cross, 1992.
4.
Linden JV, Paul B., Dressler KPA report of 104 transfusion errors in New York State. Transfusion32:601-606, 1992.
5.
Popovsky MA, Chaplin HC Jr, Moore SBTransfusion-related acute lung injury: A neglected, serious complication of chemotherapy. Transfusion32:589-592, 1992.
6.
Lane TL, Anderson KC, Goodnough LT, et al. Leukocyte reduction in blood component therapy. Ann Intern Med117:151-162, 1992.
Sloand AM, Pitt E., Chiarello RJ, et al. HIV testing. State of the art. JAMA266: 2861-2866, 1991.
9.
Carson JL, Russell LB, Taragin MI, et al. The risks of blood transfusion: The relative influence of acquired immunodeficiency syndrome and non-A, non-B hepatitis. Am J Med92:45-52, 1992.
10.
Sayers MH, Anderson KC, Goodnough LT, et al. Reducing the risk of transfusion-transmitted cytomegalovirus infection. Ann Intern Med116:55-62, 1992.
11.
Waymack JP, Yurt RW The effect of blood transfusions on immune function. V. The effect on the inflammatory response to bacterial infections. J Surg Research48:147-153, 1990.
van Aken WGDoes perioperative blood transfusion promote tumor growth?Trans Med Rev3:243-252, 1989.
14.
Blumberg N. , Heal JMTransfusion and recipient immune function . Arch Pathol Lab Med113:246-253, 1989.
15.
Perkins HATransfusion-induced immunologic unresponsiveness. Trans Med Rev2: 196-203, 1988.
16.
Iwaki Y., Cecka JM, Terasaki PIThe transfusion effect in cadaver kidney transplants—Yes or no. Transplantation49:56-59, 1990.
17.
Kaplan J., Sarniak S., Gitlin J., et al. Diminished helper:suppressor lymphocyte ratios and natural killer cell activity in recipients of repeated blood transfusions. Blood64:308-310, 1984.
18.
Gascon P., Zoumbar NC, Yound NC, et al. Immunological abnormalities in patients receiving multiple blood transfusions. Ann Intern Med100:173-177, 1984.
19.
Triulzi DJ, Vanek K., Ryan DH, et al. A clinical and immunologic study of blood transfusion and postoperative infection in spinal surgery. Transfusion32:517-524, 1992.
20.
Fernandez LA , MacSween JM, You CK, et al. Immunologic changes after blood transfusion in patients undergoing vascular surgery. Am J Surg163:263-269,1992.
21.
Triulzi DJ, Blumberg N., Heal JMAssociation of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci28:95-107, 1990.
22.
Tartter PIRisks of transfusion. In Spence RK, Munoz E, Goldman EB, eds. Alternatives to Homologous Blood Use. Denver, Colo.: Education Design, 1992, pp 1-13.
23.
Blumberg N. , Heal JMTransfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Yale J Biol Med63:429-433, 1990.
24.
Mezrow CK, Bergstein L., Tartter PIPostoperative infections following autologous and homologous blood transfusions . Transfusion32:27-30, 1992.
25.
Murphy P., Heal JM, Blumberg N.Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion31:212-217, 1991.
26.
Fernandez MC , Gottlieb M., Menitove JEBlood transfusion and postoperative infection in orthopedic patients. Transfusion32:318-322, 1992.
27.
Rudowski WJ , Scharf R., Ziemski JMIs major surgery in hemophiliac patients safe?World J Surg11:378-386, 1987.
28.
Erban SB, Kinman JL, Schwartz JSRoutine use of the prothrombin and partial thromboplastin times. JAMA263:2428-2432, 1989.
29.
McIntyre AJBlood transfusion and hemostatic management in the perioperative period. Can J Anesth39:R108-R114, 1992.
30.
Lowery TA, Clark JASuccessful implementation of maximum surgical blood ordering schedule . J Med Assoc Ga78:155-158, 1989.
31.
Kuriyan M., Kim DU Implications of utilization of a maximum surgical blood order schedule . Vox Sang57:152-154, 1989.
32.
Carson JL, Spence RK, Poses RM, et al. Severity of anemia and operative mortality and morbidity. Lancet2:727-729, 1988.
33.
Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg199:223-233, 1984.
34.
Jamieson WRE , Janusz MT, Miyagishima RT, et al. Influence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease. Circulation66:92-97, 1982.
35.
Cooperman M. , Pflug B., Martin EW Jr, et al. Cardiovascular risk factors in patients with peripheral vascular disease. Surgery84:505-509, 1978.
36.
Spence RK, Carson JA, Poses R., et al. Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg59:320-324, 1990.
37.
Spence RK, Alexander JB, DelRossi AJ, et al. Transfusion guidelines for cardiovascular surgery: Lessons learned from operations in Jehovah's Witnesses. J Vasc Surg16:825-829, 1992.
38.
Chambers LA, Kruskall MSPreoperative autologous blood donation. Trans Med Rev4: 35-46, 1990.
39.
Owings DV, Kruskall MS, Thurer RL, et al. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA262:1963-1968, 1989.
40.
Britton LW, Eastlund DT, Dziuban SW, et al. Predonated autologous blood use in elective cardiac surgery . Ann Thorac Surg47:529-532, 1989.
41.
Spiess BD, Sassetti R., McCarthy RJ, et al. Autologous blood donation: Hemodynamics in a high-risk patient population. Transfusion32:17-22, 1992.
42.
Goodnough LT , Brittenham GMLimitations of the erythropoietic response to serial phlebotomy: Implications for autologous blood donor programs . J Lab Clin Med115: 28-35, 1990.
43.
Goodnough LTErythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient. Trans Med Rev4:299-296, 1990.
44.
Renner SW, Howanitz PJ, Bachner P.Preoperative autologous blood donation in 612 hospitals. A College of American Pathologists' Q-probes study of quality issues in transfusion practice. Arch Pathol Lab Med116:613-619, 1992.
45.
Toy Ptcy , Straus RG, Stehling LC, et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med316:517-520, 1987.
46.
Robertie PG , Gravlee GPSafe limits of hemodilution and recommendations for erythrocyte transfusion. Int Anesthesiol Clin28:197-204, 1990.
47.
Stehling L. , Zauder HLAcute normovolemic hemodilution . Transfusion31:857-868, 1991.
48.
Chapler CK, Cain SMThe physiologic reserve in oxygen carrying capacity: Studies in experimental hemodilution. Can J Physiol Pharmacol64:7-12, 1986.
49.
Buckberg G. , Brazier J.Coronary blood flow and cardiac function during hemodilution. Bibl Haematol41:173-189, 1974.
50.
Wilkerson DK , Rosen AL, Sehgal LR, et al. Limits of cardiac compensation in anemic baboons. Surgery103:665-670, 1988.
51.
Geha AS, Baue AEGrade coronary stenosis and coronary flow during acute normovolemic anemia . World J Surg2:645-651, 1978.
52.
Weiskopf RBHuman response to severe hemodilution in autologous transfusion: Current trends and research issues. In Autologous Transfusion: Current Trends and Research Issues. Bethesda, Md.: NHLBI, 1992, pp 38-40.
53.
Weisel RD, Charlesworth DC, Mickleborough LL, et al. Limitations of blood conservation. J Thorac Cardiovasc Surg88:26-38, 1984.
54.
Rao TLK , Montoya A.Cardiovascular, electrocardiographic and respiratory changes following acute anemia with volume replacement in patients with coronary artery disease. Anesth Rev12:49-54, 1985.
55.
Parris WCW , Kambam JR, Blanks S., et al. The effect of intentional hemodilution on P50. J Cardiovasc Surg29:560-562, 1988.
56.
Shah DM, Prichard MN, Newell JC, et al. Increased cardiac output and oxygen transport after intraoperative isovolemic hemodilution. A study in patients with peripheral vascular disease . Arch Surg79:748-754, 1980.
57.
DelRossi AJ , Cernaiainu AC, Vertress RA, et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg100:281-286, 1990.
58.
Giordano GF , Rivers SL, Chung GKI, et al. Autologous platelet-rich plasma in cardiac surgery: Effect on intraoperative and postoperative transfusion requirements . Ann Thorac Surg46:416-419, 1988.
59.
Jones JW, McCoy TA, Rawitscher RE, et al. Effects of intraoperative plasmapheresis on blood loss in cardiac surgery. Ann Thorac Surg49:585-590, 1990.
60.
Tawes RL, Sydorak GR, Duvall TB, et al. Avoiding coagulopathy in vascular surgery. Am J Surg160:212-216, 1990.
61.
Paty PSK , Shah DS, Chang BB, et al. Immediate preoperative phlebotomy with autologous blood donation for aortic replacement. Surg Gynecol Oncol171:326-330, 1990.
62.
Aubuchon JPAutologous transfusion and directed donations: Current controversies and future directions. Trans Med Rev3:290-306, 1989.
63.
Vertrees RATechniques in autotransfusion. In Cernaianu AC, DelRosi AJ, eds. Cardiac Surgery '93: Clinical Issues. New York: Plenum Press [in press].
64.
Dzik WH, Sherburne B.Intraoperative blood salvage: Medical controversies. Trans Med Rev4:208-235, 1990.
65.
Heddle NM, Brox WT, Klama LN, et al. A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion32:742-746, 1992.
66.
Woda R., Tetzlaff JEUpper airway oedema following autologous blood transfusion from a wound drainage system. Can J Anaesth39:290-292, 1992.
67.
Sieunarine K., Lawrence-Brown MMD, Brennan D., et al. The quality of blood used for transfusion. J Cardiovasc Surg33:98-105, 1992.
68.
Kingsley JR , Valeri CR, Peters H., et al. Citrate anticoagulation and cell washing for intraoperative autotransfusion in the baboon. Am J Surg131:717-721, 1976.
Duchateau J. , Nevelsteen A., Suy R., et al. Autotransfusion during aortoiliac surgery. Eur J Vasc Surg4:349-354, 1990.
71.
Giordano GF , Giordano DM, Wallace BA, et al. An analysis of 9918 consecutive perioperative autotransfusions. Surg Gynecol Obstet176:103-110, 1993.
72.
Hallett JW Jr.Minimizing the use of homologous blood products during repair of abdominal aortic aneurysms. Surg Clin North Am69:817-826, 1989.
73.
Boudreaux JP , Bornside GH, Cohn I. Jr.Emergency autotransfusion: Partial cleansing of bacteria-laden blood by cell washing. J Trauma23:31-35, 1983.
74.
Schaff HV, Haver J., Gardner TJ, et al. Routine use of autotransfusion following cardiac surgery: Experience in 700 patients. Ann Thorac Surg27:493-499, 1979.
75.
Valeri CRRoutine postoperative salvage in orthopedic surgery for knee and hip procedures is safe and effective. In Autologous Transfusion: Current Trends and Research Issues. Bethesda, Md.: NHLBI, 1992, pp 60-61.
76.
Umlas J.Routine postoperative salvage in orthopedic surgery for knee and hip procedures is not safe and effective. In Autologous Transfusion: Current Trends and Research Issues. Bethesda, Md.: NHLBI, 1992, pp 62-63.
77.
Miller E., Paull DE, Morrissey K., et al. Scalpel versus electrocautery in modified radical mastectomy . Am Surg54:284-286, 1988.
78.
Pearlman NW , Stiegmann GV, Vance V., et al. A prospective study of incisional time, blood loss, pain and healing with carbon dioxide laser, scalpel and electrosurgery. Arch Surg126: 1018-1020, 1991.
79.
Ward PH, Castro DJ, Ward S.A significant new contribution to radical head and neck surgery. The argon beam coagulator as an effective means of limiting blood loss. Arch Otolaryngol Head Neck Surg115:921-923, 1989.
80.
Kram HB, Nathan RC, Stafford FJ, et al. Fibin glue achieves hemostasis in patients with coagulation disorders. Arch Surg124:385-388, 1989.
81.
McCarthy PMFibrin glue in cardiothoracic surgery. Trans Med Rev7:173-179, 1993.
82.
Bridenbaugh LDRegional anesthesia for outpatient surgery-A summary of 12 years' experience. Can Anaesth Soc J30:548-552, 1983.
83.
Bjoraker DGBlood transfusion. What is a safe hematocrit? Prob Crit Care5:386-399, 1991.
84.
Leather RP, Shah DM, Kaufman JL, et al. Comparative analysis of retroperitoneal and transperitoneal aortic replacement for aneurysm. Surg Gynecol Obstet168:387-393, 1989.
85.
Carrel T., Pasic M., Turina M., et al. The retroperitoneal approach: An excellent alternative to the transperitoneal route in elective aortic surgery. Int J Angiol1-5, 1992.
86.
Cambria RP, Brewster DC, Abbott WM, et al. Transperitoneal versus retroperitoneal approach for aortic reconstruction: A randomized prospective study. J Vasc Surg11: 314-325, 1990.
87.
Reid DB, Pollock JGA prospective study of 100 gelantin-sealed aortic grafts. Ann Vasc Surg5:320-324, 1991.
88.
Fisher JB, Dennis RC, Valeri CR, et al. Effect of graft material on loss of erythrocytes after aortic operations. Surg Gynecol Obstet173:130-136, 1991.
89.
Hans SS, Masi J., Goyal V., et al. Increased blood loss with in situ bypass. Am Surg56: 540-542, 1990.
90.
Schulman S.DDAVP-The multipotent drug in patients with coagulopathies Trans Med Rev [in press].
91.
Czer LSC , Bateman TM, Gray RJ, et al. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin . J Am Coll Cardiol9:1139-1147, 1987 .
92.
Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: A double blind randomized trial. N Engl J Med314:1402-1406, 1986.
93.
Rocha E., Llorens R., Paramo JA, et al. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation77:1319-1323, 1988.
94.
Hackman T., Gascoyne RD, Naiman SC, et al. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med321:1437-1443, 1989.
95.
Mammen EF, Koets MH, Urzua J., et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost11:281-292, 1985.
96.
DelRossi AJ , Cernaianu AC, Botros S., et al. Prophylactic treatment of postperfusion bleeding using EACA. Chest96:27-30, 1989.
97.
D'Ambra MN, Risk SCAprotinin, erythropoietin, and blood substitutes . Int Anesthesiol Clin28:237-240, 1990.
98.
Wildevuur RH , Eijsman L., Gu YJ, et al. Aprotinin reduces bleeding during cardiopulmonary bypass in aspirin treated patients. J Cardiovasc Surg31:34, 1990.
99.
vanOeveren W., Jansen NJ, Bidstrup BP, et al. Effects of aprotinin on hemostatic mechanism after cardiopulmonary bypass. Ann Thorac Surg44:640-645, 1987.
100.
Rovston D. , Bidstrup BP, Taylor KM, et al. Effect of aprotinin on need for transfusion after repeat open heart surgery. Lancet2:1289-1291, 1987.
101.
Levine EA, Gould SA, Rosen AL, et al. Perioperative recombinant human erythropoietin. Surgery106:432-438, 1989.
102.
Ashby ECTotal dose iron-dextran infusions in general surgery. Lancet2:807-809, 1967.
103.
Dudrick SJ , O'Donnell JJ, Raleigh DP, et al. Rapid restoration of red blood cell mass in severely anemic surgical patients who refuse transfusion . Arch Surg120:721-727, 1985.
104.
Puri VK, Paidipaty B., White L.Hydroxyethyl starch for resuscitation of patients with hypovolemia and shock . Crit Care Med9:833-837, 1981.
105.
Tremper KK, Friedman AE, Levine EM, et al. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid. Fluosol-DA. N Engl J Med307:277, 1982.
106.
Spence RK, McCoy S., Costabile J., et al. Fluosol DA-20 in the treatment of severe anemia: Randomized controlled study of 46 patients. Crit Care Med18:1227-1230, 1990.
107.
Gould SA, Rosen AL, Sehgal LR, et al. Fluosol-DA as a red cell substitute in acute anemia. N Engl J Med314:1653-1656, 1986 .
108.
Feola M., Simoni J., Tran R., et al. Nephrotoxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs18:233-249, 1990.
109.
Gould SA, Sehgal LR, Rosen AL, et al. The efficacy of polymerized pyridoxylated homoglobin solution as an O2 carrier. Ann Surg211:394-398, 1990.
110.
Krausz MM, Meital BZ, Rabinovici R., et al. "Scoop and run" or "stabilize" hemorrhagic shock by normal saline or small-volume hypertonic saline. J Trauma33:6-9, 1992.
111.
Bickell WH , Bruttig SP, Millnamoro GA, et al. The detrimental effects of intravenous crystalloid after experimental aortotomy in swine. Surgery110:529-534, 1991.
112.
Martin RR, Bickell WH, Pepe PE, et al. Prospective evaluation of preoperative fluid resuscitation in hypotensive patients with penetrating truncal injury: A preliminary report . J Trauma33:354-362, 1992.
113.
Lilly MP, Gala GJ, Carlson DE, et al. Saline resuscitation after fixed-volume hemorrhage. Role of resuscitation volume and rate of infusion. Ann Surg216:161-171, 1992.
114.
Rabinovici R., Krausz MM, Feuerstein G.Control of bleeding is essential for successful treatment of hemorrhagic shock with 7.5 per cent sodium chloride solution . Surg Gynecol Obstet173:98-106, 1991.
115.
Younes RN, Aun F., Accioly CQ, et al. Hypertonic solutions in the treatment of hypovolemic shock: A prospective, randomized study in patients admitted to the emergency room . Surgery111:380-385, 1992.
116.
Vassar MJ, Perry CA, Gannaway WL, et al. 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg126:1065-1072, 1991.
117.
Reed RL Jr, Cravarella D., Heimbach DM et al. Prophylactic platelet administration during massive transfusion: A prospective randomized, double-blind clinical study. Ann Surg203:40-48, 1986.
118.
Pimpl W., Boeckl O., Heinerman M., et al. Emergency endoscopy: A basis for therapeutic decisions in the treatment of severe gastroduodenal bleeding. World J Surg13:592-597, 1989.
119.
Lee H. , Hawker FH, Selby W., et al. Intensive care treatment of patients with bleeding esophageal varices: Results, predictors of mortality, and predictors of the adult respiratory distress syndrome. Crit Care Med20:1555-1563, 1993.
120.
Gliedman ML , Langer B., Rikkers LF, et al. Management of variceal bleeding. Surg41: 49-62, 1992.
121.
Stiegmann GV, Goff JS, Michaletz-Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med326: 1527-1532, 1992 .
122.
Burroughs AK, Hamilton G., Phillips A., et al. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med321:857-862, 1989.
123.
Berard P.Surgical treatment of hemorrhage from ruptured esophageal varices by an orally introduced clip to provoke sclerosis of the lower esophagus and ligation of the peri-esophageal veins through a thoracic approach. Results in 108 cases treated over a period of 5 years. J Chir (Paris) 121:6-7, 389-393, 1984.
124.
Nagasue N., Kohno H., Ogawa Y., et al. Appraisal of distal spinal renal shunt in the treatment of esophageal varices: An analysis of prophylactic emergency and elective shunts. World J Surg13:92-99, 1989.
125.
Harville LE, Rivera FJ, Palmaz JC, et al. Variceal hemorrhage associated with portal vein thrombosis: Treatment with a unique portal venous stent. Surgery111:585-590, 1992.
126.
Smoller BR, Kurskall MSPhlebotomy for diagnostic laboratory tests in adults: Pattern of use and effect on transfusion requirements. N Engl J Med314:1233-1235, 1986.
127.
Perioperative red cell transfusion. Natl Inst Health Consensus Dev Conf Consensus Statement7:1-17, 1988.
128.
Linman JWPhysiologic and pathophysiologic effects of anemia. N Engl J Med279: 812-818, 1968.
129.
Lunn JN, Elwood PCAnemia and surgery. Br Med J3:71-73, 1970.
130.
Rawstron ERAnemia and surgery. A retrospective clinical study. Aust N Z J Surg39: 425-432, 1970.
131.
Alexiu O., Micrea N., Balaban M., et al. Gastrointestinal hemorrhage from peptic ulcer. An evaluation of bloodless transfusion and early surgery. Anaesthesia30:609-615, 1975.
132.
Nelson AH, Fleisher LA, Rosenbaum SHThe relationship between postoperative anemia and cardiac morbidity in high risk vascular patients in the ICU [abstract]. Crit Care Med20(Suppl):S71, 1992.
133.
Christopherson R., Frank S., Norris E., et al. Low postoperative hematocrit is associated with cardiac ischemia in high-risk patients [abstract] . Anesthesiology75:A100, 1991.
134.
Goldman EB , Oberman HALegal aspects of transfusion of Jehovah's Witnesses. Trans Med Rev5:263-270, 1991.
135.
Stevens D.Negligence liability for transfusion-associated AIDS transmission. An update and proposal. J Leg Med12:221-241, 1991.
136.
Goldman EBLegal issues in blood transfusion. In Spence RK, Munoz E, Goldman EB, eds. Alternatives to Homologous Blood Use. Denver, Colo.: Education Design, 1992, pp 16-20.